Mechanisms of action of currently used antiseizure drugs
GJ Sills, MA Rogawski - Neuropharmacology, 2020 - Elsevier
Antiseizure drugs (ASDs) prevent the occurrence of seizures; there is no evidence that they
have disease-modifying properties. In the more than 160 years that orally administered …
have disease-modifying properties. In the more than 160 years that orally administered …
Hippocampal GABAergic inhibitory interneurons
KA Pelkey, R Chittajallu, MT Craig… - Physiological …, 2017 - journals.physiology.org
In the hippocampus GABAergic local circuit inhibitory interneurons represent only~ 10–15%
of the total neuronal population; however, their remarkable anatomical and physiological …
of the total neuronal population; however, their remarkable anatomical and physiological …
Transcriptional architecture of synaptic communication delineates GABAergic neuron identity
Understanding the organizational logic of neural circuits requires deciphering the biological
basis of neuronal diversity and identity, but there is no consensus on how neuron types …
basis of neuronal diversity and identity, but there is no consensus on how neuron types …
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
S Kanes, H Colquhoun, H Gunduz-Bruce, S Raines… - The Lancet, 2017 - thelancet.com
Background Post-partum depression is a serious mood disorder in women that might be
triggered by peripartum fluctuations in reproductive hormones. This phase 2 study …
triggered by peripartum fluctuations in reproductive hormones. This phase 2 study …
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
AJ Cutler, GW Mattingly, V Maletic - Translational Psychiatry, 2023 - nature.com
The pathophysiology of major depressive disorder (MDD) is thought to result from impaired
connectivity between key brain networks. Gamma-aminobutyric acid (GABA) is the key …
connectivity between key brain networks. Gamma-aminobutyric acid (GABA) is the key …
The central amygdala as an integrative hub for anxiety and alcohol use disorders
The central amygdala (CeA) plays a central role in physiologic and behavioral responses to
fearful stimuli, stressful stimuli, and drug-related stimuli. The CeA receives dense inputs from …
fearful stimuli, stressful stimuli, and drug-related stimuli. The CeA receives dense inputs from …
GABAkines–Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Positive allosteric modulators of γ-aminobutyric acid-A (GABA A) receptors or GABAkines
have been widely used medicines for over 70 years for anxiety, epilepsy, sleep, and other …
have been widely used medicines for over 70 years for anxiety, epilepsy, sleep, and other …
The GABAA receptor as a therapeutic target for neurodevelopmental disorders
S Braat, RF Kooy - Neuron, 2015 - cell.com
Intellectual disability, autism spectrum disorder, and epilepsy are prime examples of
neurodevelopmental disorders that collectively affect a significant percentage of the world …
neurodevelopmental disorders that collectively affect a significant percentage of the world …
Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors
M Schumacher, C Mattern, A Ghoumari… - Progress in …, 2014 - Elsevier
Progesterone is commonly considered as a female reproductive hormone and is well-known
for its role in pregnancy. It is less well appreciated that progesterone and its metabolite …
for its role in pregnancy. It is less well appreciated that progesterone and its metabolite …
[HTML][HTML] Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
AL Althaus, MA Ackley, GM Belfort, SM Gee, J Dai… - …, 2020 - Elsevier
Abstract Zuranolone (SAGE-217) is a novel, synthetic, clinical stage neuroactive steroid
GABA A receptor positive allosteric modulator designed with the pharmacokinetic properties …
GABA A receptor positive allosteric modulator designed with the pharmacokinetic properties …